Department of Otorhinolaryngology-Head and Neck Surgery, Albert Einstein College of Medicine, Bronx, NY.
Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY.
Int Forum Allergy Rhinol. 2018 May;8(5):605-613. doi: 10.1002/alr.22055. Epub 2017 Dec 6.
The endoscopic modified Lothrop procedure (EMLP) has been used as a salvage technique for frontal sinusitis following failed endoscopic sinus surgery (ESS). We aim to examine the safety and efficacy of the EMLP following failure of primary ESS.
All English-language publications from 2000 to 2016 reporting the use of EMLP after primary ESS were identified using the PubMed database and evaluated per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Random effects summaries of patient demographics, comorbidities, and surgical outcomes were obtained through meta-analysis.
Eleven studies constituting 778 patients were included and 86.5% had chronic rhinosinusitis (CRS). Mean follow-up duration was 28.4 months. The mean number of surgeries prior to EMLP was 3.5. Symptom improvement was reported in 82.3%. Subgroup analysis of 7 studies in which all 357 patients had CRS revealed a mean follow-up of 31.5 months. Symptom improvement occurred in 75.9% of cases and 23.1% experienced polyp recurrence. The cerebrospinal fluid leak rate was 2.5%. Restenosis of the neo-ostium occurred in 17.1% with complete closure occurring in 3.9% of cases. The reoperation rate after EMLP was 9.0%. Aspirin sensitivity was associated with an increased risk of cerebrospinal fluid (CSF) leak (p = 0.0339) and a reduced incidence of neo-ostium closure (p = 0.0001). Aspirin sensitivity and asthma were associated with a reduced incidence of reoperation (p ≤ 0.001) and increased symptom improvement (p < 0.005). Restenosis or closure of the frontal neo-ostium was associated with less symptom improvement (p < 0.04) but not with reoperation.
The EMLP is an effective salvage procedure for refractory frontal sinusitis based on data from higher-volume centers.
内镜改良洛特罗普手术(EMLP)已被用作内镜鼻窦手术(ESS)失败后额窦炎的挽救技术。我们旨在检查原发性 ESS 失败后 EMLP 的安全性和有效性。
使用 PubMed 数据库从 2000 年至 2016 年所有以英语发表的报告使用原发性 ESS 后 EMLP 的文献,并根据系统评价和荟萃分析(PRISMA)指南进行评估。通过荟萃分析获得患者人口统计学,合并症和手术结果的随机效应摘要。
共纳入 11 项研究,共 778 例患者,86.5%患有慢性鼻鼻窦炎(CRS)。平均随访时间为 28.4 个月。在 EMLP 之前的平均手术次数为 3.5 次。82.3%的患者报告症状改善。在 7 项研究中有 357 例患者均患有 CRS 的亚组分析中,平均随访时间为 31.5 个月。75.9%的病例症状改善,23.1%的病例息肉复发。脑脊液漏的发生率为 2.5%。新窦口的再狭窄发生率为 17.1%,完全关闭发生率为 3.9%。EMLP 后的再手术率为 9.0%。阿司匹林敏感性与脑脊液(CSF)泄漏的风险增加相关(p = 0.0339),与新窦口闭合的发生率降低相关(p = 0.0001)。阿司匹林敏感性和哮喘与再手术发生率降低(p ≤ 0.001)和症状改善增加(p <0.005)相关。额窦新窦口的再狭窄或闭合与症状改善减少相关(p <0.04),但与再手术无关。
根据高容量中心的数据,EMLP 是治疗难治性额窦炎的有效挽救方法。